Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Demographic characteristics of study participants.

More »

Table 1 Expand

Table 2.

Prevalence of polypharmacy by gender and age.

More »

Table 2 Expand

Fig 1.

The distribution of patient’s drug interactions categorized by severity.

More »

Fig 1 Expand

Fig 2.

Drug interaction with polypharmacy greater than or equal 5 drugs.

More »

Fig 2 Expand

Fig 3.

Drug interactions with polypharmacy greater than 9 drugs.

More »

Fig 3 Expand

Fig 4.

Specific drugs prescribed for the management of various co-morbidities.

More »

Fig 4 Expand

Fig 5.

Frequency of most common pDDIs administered among patients.

More »

Fig 5 Expand

Table 3.

Age and the number of drugs prescribed at treatment and discharge.

More »

Table 3 Expand

Table 4.

Gender and the number of drugs prescribed at treatment and discharge.

More »

Table 4 Expand

Table 5.

Age vs mild, moderate, and severe drug interactions.

More »

Table 5 Expand

Table 6.

Gender vs mild, moderate, and severe drug interactions.

More »

Table 6 Expand

Table 7.

Association between polypharmacy and predictors at Yenepoya Medical College and Hospital.

More »

Table 7 Expand

Table 8.

Potential drug-drug interactions.

More »

Table 8 Expand